Avisa Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FOGCF research report →
Price Chart
About the company
Avisa Diagnostics Inc. is a medical device company currently in its clinical development phase. The company is advancing the Avisa BreathTest, an innovative drug-device biomarker platform.
- CEO
- David S. Joseph
- IPO
- 2021
- Employees
- 3
- HQ
- Santa Fe, NM, US
Get TickerSpark's AI analysis on FOGCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $97.18K
- P/E
- -0.23
- PEG
- 0.00
- P/S
- 0.32
- P/B
- -0.32
- EV/EBITDA
- -0.20
- Div Yield
- 0.00%
- Gross Margin
- 46.53%
- Op Margin
- -251.59%
- Net Margin
- -263.83%
- ROE
- 408.59%
- ROIC
- 187.73%
Latest fiscal year · YoY change
- Revenue
- $277.83K-67.6%
- Gross Profit
- $129.28K+106.6%
- Op Income
- $-900,655
- Net Income
- $-715,762+82.7%
- EPS
- $-0.14+83.7%
- OCF Growth
- +66.4%
- FCF Growth
- +67.1%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.28
- RSI (14)
- 48
- Avg Volume
- 111.41K
No earnings-call transcripts are available for FOGCF yet.
- Free Float
- 0.0%
- Shares Outstanding
- 9.72B
- Float Shares
- 0
Our FOGCF coverage
Recent articles, reports, and earnings notes.
No research on FOGCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FOGCF report →